| scholarly article | Q13442814 |
| P2093 | author name string | G. Schmitz | |
| G. Rogler | |||
| K. J. Lackner | |||
| P2860 | cites work | The pathogenesis of atherosclerosis: a perspective for the 1990s | Q29547827 |
| A Detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis | Q34249812 | ||
| Effects of monotherapy with an HMG-CoA reductase inhibitor on the progression of coronary atherosclerosis as assessed by serial quantitative arteriography. The Canadian Coronary Atherosclerosis Intervention Trial. | Q51596506 | ||
| Requirement for mevalonate in cycling cells: quantitative and temporal aspects | Q67931587 | ||
| Relationship between mevalonate pathway and arterial myocyte proliferation: in vitro studies with inhibitors of HMG-CoA reductase | Q72547620 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | statin | Q954845 |
| P304 | page(s) | 114A-116A | |
| P577 | publication date | 1995-07-01 | |
| 1995-07-13 | |||
| P1433 | published in | American Journal of Cardiology | Q2208417 |
| P1476 | title | Effects of fluvastatin on growth of porcine and human vascular smooth muscle cells in vitro | |
| Effects of flwastatin on growth of porcine and human vascular smooth muscle cells in vitro | |||
| P478 | volume | 76 |
| Q35756752 | Association of dyslipidemia and effects of statins on nonmacrovascular diseases |
| Q33843636 | C-reactive protein, inflammation, and coronary risk |
| Q79299389 | C-reactive protein, inflammation, and coronary risk |
| Q41141172 | Differentiated properties and proliferation of arterial smooth muscle cells in culture. |
| Q36577189 | Drug insight: Immunomodulatory effects of statins--potential benefits for renal patients? |
| Q73176738 | HMG CoA reductase inhibitors are related to improved systemic endothelial function in coronary artery disease |
| Q44620895 | Inhibition of Hydroxymethylglutaryl-Coenzyme A Reductase Reduces Th1 Development and Promotes Th2 Development |
| Q50522879 | Inhibitory effect of photooxidation on intimal and medial thickening of saphenous vein. |
| Q22241432 | Role of HMG-CoA Reductase Inhibitors in Neurological Disorders |
| Q77220461 | Simvastatin decreases aldehyde production derived from lipoprotein oxidation |
| Q41169571 | Statins do more than just lower cholesterol |
| Q46506824 | The HMG-CoA reductase inhibitor rosuvastatin and the angiotensin receptor antagonist candesartan attenuate atherosclerosis in an apolipoprotein E-deficient mouse model of diabetes via effects on advanced glycation, oxidative stress and inflammation |
| Q33818141 | The evolving role of statins in the management of atherosclerosis |
Search more.